CN1030183A - A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use - Google Patents
A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use Download PDFInfo
- Publication number
- CN1030183A CN1030183A CN 87104599 CN87104599A CN1030183A CN 1030183 A CN1030183 A CN 1030183A CN 87104599 CN87104599 CN 87104599 CN 87104599 A CN87104599 A CN 87104599A CN 1030183 A CN1030183 A CN 1030183A
- Authority
- CN
- China
- Prior art keywords
- radix
- heart disease
- coronary heart
- powder
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use, be action principle according to cooperative effect, will have blood circulation promoting and blood stasis dispelling, eliminating phlegm dampness removing, diffusion blood vessel, causing resuscitation with aromatic drugs, twenty flavor Chinese medicine dryings such as the Radix Scrophulariae of enriching blood, going into various effects such as the god of Dingan County of regulating the flow of vital energy, Radix Angelicae Sinensis, Rhizoma Acori Graminei, Pericarpium Zanthoxyli, Ramulus Cinnamomi, Bulbus Allii Macrostemonis, Borneolum Syntheticum, Radix Notoginseng, pulverize, sieve, mixing and stirring and getting.The present invention is made medicated bag, put left front, not only can treat coronary heart disease, and can prevent coronary heart disease, life-time service has no side effect, and makes people's slow down aging, improves health life lengthening.
Description
The invention belongs to a kind of processing method of Chinese patent medicine, the specifically a kind of processing method that can not only treat and can prevent the Chinese patent medicine of coronary heart disease by the dermal osmosis effect.
The people steps into the middle age, particularly to old age, because of the ductus arteriosus wall sclerosis, sugar and lipid component increase in the blood, vessel wall thickening, tube chamber are narrowed down, and at first are that the coronary artery tube chamber of heart narrows down, and cause blood flow to reduce, myocardial ischemia-anoxemia, the cardiac function decline, whenever rich output, per minute output reduce, its mild symptoms is then uncomfortable in chest, pareordia dull pain, hypomnesis quickens old and feeble, heavy then myocardial infarction, threat to life.At present coronary heart disease is not still had effective prophylactic agent, have only when angina pectoris outbreak or myocardial infarction bring disaster to life and just treated.Doctor trained in Western medicine general oral nitroglycerin class first aid or oral practolol, propranolol, segondin, isoptin, nifedipine, persantin etc., with coronary artery dilator, reduce myocardial oxygen consumption, recover the equilibrium of supply and demand of cardiac muscle, improve myocardial ischemia, cardiac function enhancing oxygen, the said medicine effect is fast, evident in efficacy, but take for a long time, bad side effect will be produced to brain, nerve, vision, audition, chamber conduction, digestive tract even skin; Chinese traditional treatment generally is that oral arklemin closes ball, the chest stuffiness relieving ball, gualou xiebai semi-soup plus-minus, zhigancao decoction plus-minus, GUIPI TANG plus-minus etc., perhaps intramuscular injection, intravenous injection Radix Salviae Miltiorrhizae Injection, Radix Ilicis Pubescentis injection, Rhizoma Chuanxiong injection etc., above Chinese medicine also has certain therapeutical effect, but curative effect is slow, and part patient has side reactions such as loss of appetite, gastrointestinal upset.In recent years, adopt in blood vessel the way of device cholesterol filter abroad, reducing the composition of blood fat in the blood, thereby alleviate or delay arteriosclerotic development, obviously this legal medical expert treats the equipment requirements height, and the expense costliness can not penetration and promotion.
The object of the present invention is to provide a kind of processing method of Chinese patent medicine, the patent medicine that makes is used for prevention and treatment coronary heart disease, does not need orally, makes medicated bag, puts the front, play illly cure the disease, the effect of anosis diseases prevention.
The present invention has the action principle of mutual cooperative effect according to herbal nature, having blood circulation promoting and blood stasis dispelling, the eliminating phlegm dampness removing, blood vessel dilating, cardiac function enhancing, reduce the Chinese medicine such as the Radix Scrophulariae of the myocardial oxygen consumption property of medicine, Radix Angelicae Sinensis, Semen Cassiae, Yin Jiye, Radix Curcumae, Rhizoma Corydalis, Flos Carthami, Myrrha, Olibanum is equal to causing resuscitation with aromatic drugs, it is strong to walk to scurry power, can go into the Rhizoma Acori Graminei that the heart is had one's ideas straightened out and made skin capillary vascular expansion, Pericarpium Zanthoxyli etc. and have promoting the flow of QI in the collateral by warming the meridian, regulate the flow of vital energy and enrich blood, go into the Ramulus Cinnamomi of the refreshing effect in Dingan County, Bulbus Allii Macrostemonis, Fructus Trichosanthis, Radix Codonopsis, the Radix Astragali, Lignum Dalbergiae Odoriferae, totally 18 flavors such as Polygonm multiflorum Thunb Tengs etc. respectively get certain amount, become powder through processing, then with powder with a certain amount of Radix Notoginseng powder and Borneolum Syntheticum powder face mixing and stirring, promptly obtain preventing and treating the external Chinese patent medicine of coronary heart disease.
Concrete consumption and manufacture method are as follows: use weight percent meter, getting 4.3% Radix Scrophulariae, 5.8% Radix Angelicae Sinensis, 4.3% Semen Cassiae, 4.3% Yin Jiye, 4.3% Radix Curcumae, 5.1% Rhizoma Corydalis, 5.1% Flos Carthami, 5.1% Myrrha, 5.1% Olibanum, 5.1% Rhizoma Acori Graminei, 5.1% Pericarpium Zanthoxyli, 5.1% Ramulus Cinnamomi, 5.1% Bulbus Allii Macrostemonis, 5.1% Fructus Trichosanthis, 5.1% Radix Codonopsis, 5.1% Radix Astragali, 5.1% Lignum Dalbergiae Odoriferae, 5.1% Polygonm multiflorum Thunb Teng puts in the low temperature drying baker, in about 50 ℃ Celsius dry 5 hours, put sombre dry place after the taking-up cool 5 hours, pulverize through pulverizer then, cross 80 mesh sieves, waste stays powder stand-by; Get the mixing of 5.4% Borneolum Syntheticum and 5.3% Radix Notoginseng powder and smash the grind up face, at last both mixing and stirring are promptly got product.
External method of the present invention is as follows: the cloth bag of manufacturing 15 centimetres of about 10 cm x of size with jaconet or other fiber cloth, seal about interior powder charge powder 300 grams, this medicated bag is seated in the left front of anatomical cardiac position, common one bag can keep curative effect 20~30 days, and change one bag again to after date.The method of putting can be to make a bound pocket in the corresponding place of cardiac position on the Left forepart of underskirt or on the cotton dress, overcoat lining, in put medicated bag, be through and promptly play prevention and therapeutical effect on one's body, if in the winter time, can use hand warmer, quicken the osmosis of the property of medicine.
Advantage of the present invention is to need not the doctor to instruct, can use voluntarily, wear for a long time, have no side effect, make people's slow down aging, improve health, life lengthening can be treated patients with coronary heart disease, prevent angina pectoris and myocardial infarction, do not influence work, study, guarantee out on tours safety, can prevent the generation of coronary heart disease to ordinary person.
To make the present invention's 1000 grams is example, the auspicious embodiment of stating is as follows: take by weighing Radix Scrophulariae 43 grams, Radix Angelicae Sinensis 58 grams, Semen Cassiae 43 grams, Yin Jiye 43 grams, Radix Curcumae 43 grams, Rhizoma Corydalis 51 grams, Flos Carthami 51 grams, Myrrha 51 grams, Olibanum 51 grams, Rhizoma Acori Graminei 51 grams, Pericarpium Zanthoxyli 51 grams, Ramulus Cinnamomi 51 grams, Bulbus Allii Macrostemonis 51 grams, Fructus Trichosanthis 51 grams, Radix Codonopsis 51 grams, the Radix Astragali 51 grams, Lignum Dalbergiae Odoriferae 51 grams, Polygonm multiflorum Thunb Teng 51 grams, put into porcelain dish, send into the far infrared baking oven, in about 50 ℃ Celsius dry 5 hours, put into exsiccator after the taking-up, placed 5 hours at the place in the cool place, pulverize through pulverizer then, cross 80 mesh sieves, waste stays powder stand-by; Take by weighing Borneolum Syntheticum 54 grams, Radix Notoginseng powder 53 restrains and smash the grind up face in mortar, and both mixing and stirring are promptly got product.
The present invention is as follows through Medical University Of Anhui's Internal Medicine-Cardiovascular Dept. and Anhui Chinese Medicine College affiliated hospital tcm internal medicine clinical practice 64 routine results:
1, haemodynamics is improved situation: clinical proof, and behind this medicine of Coronary Heart Disease Patients external application, blood pressure does not generally change, especially diastolic pressure, but decreased heart rate, whenever rich output, minute output, whenever rich exponential sum cardiac index obviously increases, total all resistances obviously descend, and blood viscosity also descends to some extent.
2, electrocardiogram situation of change: primary ST-T variation person 17 examples among the 54 routine patients, behind this medicine of external application, the check value of ECG ST-T changed in 24 hours, obviously improver's 7 examples.
3, patient's subjective symptom is improved situation: the overwhelming majority originally all had the symptoms such as uncomfortable in chest, precordial pain among the 64 routine patients, and behind this medicine of external application, mostly secret anguish disappears, broad-minded, breathe unimpededly, go to sleep peacefully, the sense of waking up and doubly feeling light, some typical patient angina pectoris disappear.
Claims (2)
1, a kind of manufacture method of preventing and treating the coronary heart disease medicine for external use is with tens of flavor Chinese medicine dryings, pulverizes, sieves, mixes, and it is characterized in that:
(1) with a certain amount of Radix Scrophulariae, Radix Angelicae Sinensis, Semen Cassiae, Yin Jiye, Radix Curcumae, Rhizoma Corydalis, Flos Carthami, Myrrha, Olibanum, Rhizoma Acori Graminei, Pericarpium Zanthoxyli, Ramulus Cinnamomi, Bulbus Allii Macrostemonis, Fructus Trichosanthis, Radix Codonopsis, the Radix Astragali, Lignum Dalbergiae Odoriferae, Polygonm multiflorum Thunb Teng totally 18 the flavor Chinese medicines, descended dry 5 hours at about 50 ℃ Celsius together, again in sombre dry place cold 5 hours, pulverized 80 mesh sieves then, waste stays powder;
(2) get a certain amount of Borneolum Syntheticum and Radix Notoginseng powder and smash the grind up face jointly;
(3) with above-mentioned two kinds of powder (or powder face) mixing and stirring.
2, a kind of manufacture method of preventing and treating the coronary heart disease medicine for external use according to claim 1 is characterized in that above-mentioned twenty flavor Chinese medicine weight percentage separately is as follows:
Radix Scrophulariae 4.3%, Radix Angelicae Sinensis 5.8%, Semen Cassiae 4.3%, Yin Jiye 4.3% Radix Curcumae 4.3%, Rhizoma Corydalis 5.1%, Flos Carthami 5.1%, Myrrha 5.1%, Olibanum 5.1%, Rhizoma Acori Graminei 5.1%, Pericarpium Zanthoxyli 5.1%, Ramulus Cinnamomi 5.1%, Bulbus Allii Macrostemonis 5.1%, Fructus Trichosanthis 5.1%, Radix Codonopsis 5.1%, the Radix Astragali 5.1%, Lignum Dalbergiae Odoriferae 5.1%, Polygonm multiflorum Thunb Teng 5.1%, Borneolum Syntheticum 5.4%, Radix Notoginseng powder 5.3%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 87104599 CN1018792B (en) | 1987-06-30 | 1987-06-30 | Preparing method of a medicine externally used for preventing and treating cornary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 87104599 CN1018792B (en) | 1987-06-30 | 1987-06-30 | Preparing method of a medicine externally used for preventing and treating cornary heart disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1030183A true CN1030183A (en) | 1989-01-11 |
CN1018792B CN1018792B (en) | 1992-10-28 |
Family
ID=4814942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 87104599 Expired CN1018792B (en) | 1987-06-30 | 1987-06-30 | Preparing method of a medicine externally used for preventing and treating cornary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1018792B (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2725621A1 (en) * | 1994-10-13 | 1996-04-19 | Aurele Henri Toussai Mannarini | AROMATIC COMPOSITION AND ITS APPLICATIONS IN PARTICULAR IN PHARMACEUTICAL OR COSMETIC PRODUCTS, PERFUMES OR SANITARY AND HYGIENE PRODUCTS |
CN1039197C (en) * | 1992-12-13 | 1998-07-22 | 湖北省咸宁制药厂 | Qi-invigorating oral liquid |
CN1044971C (en) * | 1992-04-28 | 1999-09-08 | 焦志军 | Preparation method of Dantian heart-strengthening plaster |
CN1055630C (en) * | 1996-10-25 | 2000-08-23 | 昆明医学院第一附属医院 | Pseudo-ginseng and salvia miltiorrhiza tablet and preparation method thereof |
CN1061549C (en) * | 1997-09-02 | 2001-02-07 | 杜廷海 | Guanxinshu inhalation for coranary heart disease and its production process |
CN1085083C (en) * | 1993-02-17 | 2002-05-22 | 山海丹企业集团西安中医多学科研究所 | Prescription and production method of medicine to cure stenocardia-type coronary heart disease |
CN1085082C (en) * | 1993-02-17 | 2002-05-22 | 山海丹企业集团西安中医多学科研究所 | Recipe of Fumailing for curing arrhythmic coronary heart disease and producing method |
CN102078421A (en) * | 2010-12-08 | 2011-06-01 | 何永恒 | Chinese medicine external preparation for postoperative analgesia and healing promotion and preparation method thereof |
CN105343358A (en) * | 2015-12-18 | 2016-02-24 | 高松武 | Traditional Chinese medicine capsules for treating coronary heart disease |
CN105582280A (en) * | 2016-01-21 | 2016-05-18 | 李宪秋 | Traditional Chinese medicine preparation for treating angina pectoris of coronary heart disease |
-
1987
- 1987-06-30 CN CN 87104599 patent/CN1018792B/en not_active Expired
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1044971C (en) * | 1992-04-28 | 1999-09-08 | 焦志军 | Preparation method of Dantian heart-strengthening plaster |
CN1039197C (en) * | 1992-12-13 | 1998-07-22 | 湖北省咸宁制药厂 | Qi-invigorating oral liquid |
CN1085083C (en) * | 1993-02-17 | 2002-05-22 | 山海丹企业集团西安中医多学科研究所 | Prescription and production method of medicine to cure stenocardia-type coronary heart disease |
CN1085082C (en) * | 1993-02-17 | 2002-05-22 | 山海丹企业集团西安中医多学科研究所 | Recipe of Fumailing for curing arrhythmic coronary heart disease and producing method |
FR2725621A1 (en) * | 1994-10-13 | 1996-04-19 | Aurele Henri Toussai Mannarini | AROMATIC COMPOSITION AND ITS APPLICATIONS IN PARTICULAR IN PHARMACEUTICAL OR COSMETIC PRODUCTS, PERFUMES OR SANITARY AND HYGIENE PRODUCTS |
WO1996011694A2 (en) * | 1994-10-13 | 1996-04-25 | Gombert, Bernard | AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF |
WO1996011694A3 (en) * | 1994-10-13 | 1996-07-25 | Gombert Bernard | AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF |
CN1055630C (en) * | 1996-10-25 | 2000-08-23 | 昆明医学院第一附属医院 | Pseudo-ginseng and salvia miltiorrhiza tablet and preparation method thereof |
CN1061549C (en) * | 1997-09-02 | 2001-02-07 | 杜廷海 | Guanxinshu inhalation for coranary heart disease and its production process |
CN102078421A (en) * | 2010-12-08 | 2011-06-01 | 何永恒 | Chinese medicine external preparation for postoperative analgesia and healing promotion and preparation method thereof |
CN105343358A (en) * | 2015-12-18 | 2016-02-24 | 高松武 | Traditional Chinese medicine capsules for treating coronary heart disease |
CN105582280A (en) * | 2016-01-21 | 2016-05-18 | 李宪秋 | Traditional Chinese medicine preparation for treating angina pectoris of coronary heart disease |
Also Published As
Publication number | Publication date |
---|---|
CN1018792B (en) | 1992-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101991816B (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases | |
CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
CN106309972A (en) | Traditional Chinese medicine composition for prevention and external treatment of diabetes and use method | |
CN101716242B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
CN1030183A (en) | A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use | |
CN102114231A (en) | Medicine for treating arrhythmia | |
CN102580030B (en) | External traditional Chinese medicine composition having effect of reducing blood sugar, preparation prepared from the external traditional Chinese medicine composition, and their preparation method | |
CN100574800C (en) | A kind of Chinese patent medicine for the treatment of atherosclerosis of cardio-cerebral arteria and preparation method thereof | |
CN103071115A (en) | Traditional Chinese medicine preparation for treating coronary sclerosis | |
CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
CN103212044B (en) | Traditional Chinese medicine composition for treating cardiovascular diseases | |
CN105998217A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and preparation method | |
CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
CN111529659A (en) | Traditional Chinese medicine composition for treating bradyarrhythmia and preparation method and application thereof | |
CN104873685A (en) | Medicine for treating coronary heart disease | |
CN101085165A (en) | Internal-applied traditional Chinese medicine composition for treating viral myocarditis | |
CN109999098A (en) | It is a kind of for treating the traditional Chinese medicine for external application of cancer-related sleep disturbance | |
CN104547973A (en) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof | |
CN103182035B (en) | Traditional Chinese medicine composition used for treating chronic arrhythmia of elderly people and preparation method of traditional Chinese medicine composition | |
CN103520647B (en) | A kind of adjustment hyperlipidemia Chinese medicine preparation | |
CN102961540A (en) | Medicine for treating coronary heart disease and preparation method for same | |
CN106177422A (en) | A kind of Chinese medicine formula of warming YANG to expel cold | |
CN106266334A (en) | A kind of Chinese medicine composition treating fat concurrent hyperlipemia and acupuncture and drugs application | |
CN105560561A (en) | Traditional Chinese medicine for treating aconuresis | |
CN104189850A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C13 | Decision | ||
GR02 | Examined patent application | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |